2009 ACTRIMS ABSTRACTS: Oral Presentations

Abstract

Get full access to this article

View all access options for this article.

References

Ascherio, A. , Munger, KL Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61: 288-299.

Ascherio, A. , Munger, KL Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61: 504-513.

Munger, KL , Zhang, SM , O’Reilly, E. , et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-65.

Munger, KL , Levin, LI , Hollis, BW , et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis . JAMA 2006; 296: 2832-2838.

Hernán, MA , Olek, MJ , Ascherio, A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001; 154: 69-74.

Ebers, GC , Sadovnick, AD , Risch, NJ A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995; 377: 150-151.

Sadovnick, AD , Ebers, GC , Dyment, DA , Risch, NJ Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728-1730.

Warner, HB , Carp, RI Multiple sclerosis and Epstein-Barr virus. Lancet 1981; 2: 1290.

Thacker, EL , Mirzaei, F. , Ascherio, A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis . Ann Neurol 2006; 59: 499-503.

10.

Ascherio, A. , Munger, KL , Lennette, ET , Spiegelman, D. , Hernan, MA , Olek, MJ , Hankinson, SE , Hunter, DJ Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286: 3083-3088.

11.

Alotaibi, S. , Kennedy, J. , Tellier, R. , Stephens, D. , Banwell, B. Epstein-Barr virus in pediatric multiple sclerosis . JAMA 2004; 291: 1875-1879.

12.

Sundstrom, P. , Juto, P. , Wadell, G. , Hallmans, G. , Svenningsson, A. , Nystrom, L. , Dillner, J. , Forsgren, L. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004; 62: 2277-2282.

13.

Levin, LI , Munger, KL , Rubertone, MV , Peck, CA , Lennette, ET , Spiegelman, D. , Ascherio, A. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496-2500.

14.

Lunemann, JD , Kamradt, T. , Martin, R. , Munz, C.

Epstein Barr virus: environmental trigger of multiple sclerosis?

J Virol 2007; 81: 6777-6784.

15.

Munz, C. , Lunemann, JD , Getts, MT , Miller, SD Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 2009; 9: 246-258.

16.

Lunemann, JD , Edwards, N. , Muraro, PA , Hayashi, S. , Cohen, JI , Munz, C. , Martin, R. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006; 129: 1493-1506.

17.

Lunemann, JD , Jelcic, I. , Roberts, S. , Lutterotti, A. , Tackenberg, B. , Martin, R. , Munz, C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008; 205: 1763-1773.

18.

Lunemann, JD , Huppke, P. , Roberts, S. , Bruck, W. , Gartner, J. , Munz, C. Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology 2008; 71: 1033-1035.

19.

Lunemann, JD , Frey, O. , Eidner, T. , Baier, M. , Roberts, S. , Sashihara, J. , Volkmer, R. , Cohen, JI , Hein, G. , Kamradt, T. , Munz, C. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis . J Immunol 2008; 181: 991-1000.

20.

Kang, I. , Quan, T. , Nolasco, H. , Park, sSH , Hong, MS , Crouch, J. , Pamer, EG , Howe, JG , Craft, J. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004; 172: 1287-1294.

21.

Jilek, S. , Schluep, M. , Meylan, P. , Vingerhoets, F. , Guignard, L. , Monney, A. , Kleeberg, J. , Le Goff, G. , Pantaleo, G. , Du Pasquier, RA Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis . Brain 2008; 131: 1712-1721.

22.

Pender, MP , Csurhes, PA , Lenarczyk, A. , Pfluger, CM , Burrows, SR. Decreased T-cell reactivity to Epstein-Barr virus-infected lymphoblastoid cell lines in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 498-505.

23.

Soldan, SS , Berti, R. , Salem, N. , Secchiero, P. , Flamand, L. , Calabresi, P. , Brennan, MB , Maloni, HW , McFarland, HF , Lin, H. , Patnaik, M. , Jacobson, S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3: 1394-1397.

24.

Donati, D. , Ahkyani, N. , Fogdell-Hahn, A. , Cermelli, C. , Vortmeyer, A. , Heiss, JD , Cogen, P. , Gaillard, WD , Sato, S. , Theodore, WH , Jacobson, S. Detection of human herpesvirus 6 (HHV-6) in mesial temporal lobe epilepsy surgical brain resections. Neurology 2003; 61: 1405-1411.

25.

Soldan, SS , Goodman, AD , Jacobson, S. HHV-6 and the central nervous system. In Perspectives in medical virology: human herpesvirus-6 (2nd ed), edited by G Krueger , DV Ablashi , 213-223. Amsterdam: Elsevier , 2006.

26.

Yao, K. , Gagnon, S. , Akhyani, N. , Williams, E. , Fotheringham, J. , Frohman, E. , Stuve, O. , Monson, N. , Racke, MK , Jacobson, S. Reactivation of HHV-6 in natalizumab treated MS patients. Plos One 2008; 3(4): e2028 (doi:10.1371/journal.pone.0002028).

27.

Yao, K. , Honarmand, S. , Espinoza, A. , Akhyani, N. , Glaser, C. , Jacobson, S. Increased detection of human herpesvirus 6 in cerebrospinal fluids of patients with encephalitis of unknown origin. Ann Neurol 2009; 65(3): 257-267.

28.

Adams, JS , Sharma, OP , Gacad, MA , Singer, FR Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 1983; 72: 1856-1860.

29.

Lemire, JM , Adams, JS 1,25-dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T cell clone. J Bone Miner Res 1992; 7: 171-177.

30.

Adams, JS , Hewison, M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4: 80-90.

31.

Liu, PT , Stenger, S. , Li, H. , Wenzel, L. , Tan, BH , Krutzik, SR , Ochoa, MT , Schauber, J. , Wu, K. , Meinken, C. , Kamen, DL , Wagner, M. , Bals, R. , Steinmeyer, A. , Zugel, U. , Gallo, RL , Eisenberg, D. , Hewison, M. , Hollis, BW , Adams, JS , Bloom, BR , Modlin, RL Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.

32.

Hewison, M. , Freeman, L. , Hughes, SV , Evans, KN , Bland, R. , Eliopoulos, AG , Kilby, MD , Moss, PA , Chakraverty, R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170: 5382-5390.

33.

Gombart, AF , Borregaard, N. , Koeffler, HP Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005; 19: 1067-1077.

34.

Daniel, C. , Sartory, NA , Zahn, N. , Radeke, HH , Stein, JM Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33.

35.

Adams, JS , Ren, S. , Liu, PT , Chun, RF , Lagishetty, V. , Gombart, AF , Borregaard, N. , Modlin, RL , Hewison, M. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182: 4289-4295.

36.

Ascherio, A. , Munger, KL Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61: 504-513.

37.

Ebers, GC Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-277.

38.

Prosser, DE , Jones, G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29: 664-673.

39.

Hayes, CE , Cantorna, MT , DeLuca, HF Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997; 216: 21-27.

40.

Kragt, J. , van Amerongen, B. , Killestein, J. , Dijkstra, C. , Uitdehaag, B. , Polman, C. , Lips, P. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009; 15: 9-15.

41.

Soilu-Hanninen, M. , Laaksonen, M. , Laitinen, I. , Eralinna, JP , Lilius, EM , Mononen, I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 152-157.

42.

van der Mei, IA , Ponsonby, AL , Dwyer, T. , Blizzard, L. , Taylor, BV , Kilpatrick, T. , Butzkueven, H. , McMichael, AJ Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 2007; 254: 581-590.

43.

Smolders, J. , Menheere, P. , Kessels, A. , Damoiseaux, J. , Hupperts, R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008; 14: 1220-1224.

44.

Torkildsen, O. , Knappskog, PM , Nyland, HI , Myhr, KM Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Archiv Neurol 2008; 65: 809-811.

45.

Niino, M. , Fukazawa, T. , Yabe, I. , Kikuchi, S. , Sasaki, H. , Tashiro, K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 2000 ; 177: 65-71.

46.

Ramagopalan, SV , Maugeri, NJ , Handunnetthi, L. , Lincoln, MR , Orton, SM , Dyment, DA , Deluca, GC , Herrera, BM , Chao, MJ , Sadovnick, AD , Ebers, GC , Knight, JC Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.

47.

Wingerchuk, DM , Lesaux, J. , Rice, GP , Kremenchutzky, M. , Ebers, GC 2005. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1294-1296.

48.

Cantorna, MT , Hayes, CE , DeLuca. HF 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 7861-7864.

49.

Spach, KM , Hayes, CE Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175: 4119-4126.

50.

Spach, KM , Nashold, FE , Dittel, BN , Hayes, CE IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 6030-6037.

51.

Pedersen, LB , Nashold, FE , Spach, KM , Hayes, CE 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 2007; 85: 2480-2490.

52.

Rich, SS , Onengut-Gumuscu, S. , Concannon, P. Recent progress in the genetics of diabetes. Horm Res 2009; 71(Suppl. 1): 17-23.

53.

Karvonen, M. , Viik-Kajander, M. , Moltchanova, E. , Libman, I. , LaPorte, R. , Tuomilehto, J. Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516-1526.

54.

Kontiainen, S. , Scheinin, T. , Schlenzka, A. , Maenpaa, J. , Groop, L. , Koskimies, S. Differences in HLA types in children with insulin-dependent diabetes diagnosed in 1960s, 1970s, and 1980s. Lancet 1988; 2: 219.

55.

Maenpaa, A. , Kostimies, S. , Scheinin, T. , Schlenzka, A. , Akerblom, HK , Maenpaa, J. , Reunanen, A. , Kontiainen, S. Frequencies of HLA-DR3, -DR4, -B8 and -Bw62 in diabetic children diagnosed between 1960 and 1990. Diabetes Res 1991; 16: 159-163.

56.

Hermann, R. , Knip, M. , Veijola, R. , Simell, O. , Laine, AP , Akerblom, HK , Groop, PH , Forsblom, C. , Pettersson-Fernholm, K. , Ilonen, J.

Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes: indication of an increased environmental pressure?

Diabetologia 2003; 46: 420-425.

57.

Gillespie, KM , Bain, SC , Barnett, AH , Bingley, PJ , Christie, MR , Gill, GV , Gale, EA The rising incidence of childhood type 1 diabetes and reduced contribution of high risk HLA haplotypes. Lancet 2004; 364: 1699-1700.

58.

Vehik, K. , Hamman, RF , Lezotte, D. , Norris, JM , Klingensmith, GJ , Rewers, M. , Dabelea, D. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care 2008; 31: 1392-1396.

59.

Fourlanos, S. , Varney, MD , Tait, BD , Morahan, G. , Honeyman, MC , Colman, PG , Harrison, LC The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008; 31: 1546-1549.

60.

Resic-Lindehammer, S. , Larsson, K. , Ortqvist, E. , Carlsson, A. , Cederwall, E. , Cilio, CM , Ivarsson, S-A. , Jonsson, BA , Larsson, HE , Lynch, K. , Neiderud, J. , Nilsson, A. , Sjoblad, S. , Lernmark, A and the Swedish Childhood Diabetes Study Group. Temporal trends of the HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol 2008; 45: 231-235.

61.

Kostraba, JN , Cruickshanks, KJ , Lawler-Heavner , J. , Jobin, LF , Rewers, M. , Gay , EC , et al. Early exposure to cow’s milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 1993; 42: 288-295.

62.

Perez-Bravo, F. , Carrasco, E. , Gutierrez-Lopez Martinez, MT , Lopez, G. , Garcia de los Rios, M. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J Mol Med 1996; 74: 105-109.

63.

Stene, LC , Ronningen, KS , Magnus, P. , Joner, G. Does HLA genotype influence the relative risk of type 1 diabetes conferred by dietary factors. Diabet Med 2002; 19: 429-433.

64.

Stene, LC , Thorsby, PM , Berg, JP , Ronningen, KS , Joner, G. , The Norwegian Childhood Diabetes Study Group. Peroxisome proliferator-activated receptor-g2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes. Pediatr Diabetes 2008; 9: 40-45.

65.

Orton, SM , Herrrera, BM , Yee, IM , Valdar, W. , Ramagopalan, SV , Sadovnick, AD , Ebers, GC , for the Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5(11): 932-936.

66.

Banwell, B. , Kennedy, J. , Sadovnick, AD , Arnold, DL , Magalhaes, S. , Wambera, K. , Connolly, MB , Yager, J. , Mah, JK , Shah, N. , Sebire, G. , Meaney, B. , Dilenge, M-E. , Lortie, A. , Whiting, S. , Doja, A. , Levin, S. , MacDonald, EA , Meek, D. , Wood, E. , Lowry, N. , Buckley, D. , Yim, C. , Awuku, M. , Guimond, C. , Cooper, P. , Grand’Maison, F. , Baird, JB , Bhan, V. , Bar-Or, A. The incidence of acquired demyelination of the central nervous system in Canadian children. Neurology 2009; 72: 232-239.

67.

Orton, SM , Ramagopalan, SV , Brocklebank, D. , Herrera, BM , Dyment, DA , Yee, IM , Sadovnick, AD , Ebers, GC Effect of immigration on multiple sclerosis gender ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry 2009; in press.

68.

Chao, MJ , Ramagopalan, SV , Herrera, BM , Lincoln, MR , Dyment, DA , Sadovnick, AD , Ebers, GC Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009; 18: 261-266.

69.

De Jager, PL , Simon, KC , Munger, KL , Rioux, JD , Hafler, DA , Ascherio, A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008; 70(13 Pt 2): 1113-1118.

70.

Sundstrom, P. , Nystrom, L. , Jidell, E. , Hallmans, G. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult Scler 2008; 14(8): 1120-1122.

71.

Zivadinov, R. , Weinstock-Guttman , B. , Zorzon, M. , Uxa , L. , Serafin, M. , Bosco, A. , et al. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. J Neuroimmunol 2009 ; 209(1-2): 123-130.

72.

De Jager, PL , et al. A meta-analysis of genome scans and replication validate new MS susceptibility loci at TNFRSF1A, ICSBP1, and CD6 . Nat Genet 2009; Jul; 41(7):776-782.